As of September 30, 2026, Well Health Technologies Corp. carries a market capitalization of 819.89M, placing it among publicly traded companies globally. Its enterprise value stands at 1.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 819.89M |
| Enterprise Value | 1.48B |
Well Health Technologies Corp.'s next confirmed earnings release is scheduled for March 25, 2027.
| Earnings Date | 3/25/2027 |
As of September 30, 2026, Well Health Technologies Corp. has 256.05M shares outstanding.
| Shares Outstanding | 256.05M |
These figures are as of September 30, 2026. The price-to-sales ratio is 0.74, and the price-to-book ratio stands at 1.46.
| PS Ratio | 0.74 |
| PB Ratio | 1.46 |
| P/TBV Ratio | -1.35 |
| P/FCF Ratio | 15.84 |
| P/OCF Ratio | 10.19 |
As of September 30, 2026, Well Health Technologies Corp. trades at an EV/EBITDA multiple of 19.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.35 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 802.24 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.48B versus a market cap of 819.89M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 1.35 |
| EV / EBITDA | 19.48 |
| EV / EBIT | 802.24 |
As of September 30, 2026, Well Health Technologies Corp. maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 86.88, indicating elevated leverage, while an interest coverage ratio of 1.05 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.76 |
| Quick Ratio | 1.59 |
| Debt / Equity | 86.88 |
| Debt / EBITDA | 8.40 |
| Interest Coverage | 1.05 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 342,813.49 in revenue per employee across its workforce of 3,200.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 342,813.49 |
| Employee Count | 3,200.00 |
Over the twelve months ended September 30, 2026, Well Health Technologies Corp. recorded an income tax benefit of -2.55M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -84.51M and -90.50M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | -2.55M |
As of the close on November 16, 2026, Well Health Technologies Corp.'s stock has declined approximately 10.88% over the past 52 weeks. The 50-day moving average sits at 2.98, while the 200-day moving average is 3.01.
| 52-Week Price Change | -10.88% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.01 |
Over the twelve months ended September 30, 2026, Well Health Technologies Corp. generated 1.10B in revenue and converted that into -90.50M in net income, yielding earnings per share of -0.32. EBITDA reached 76.23M, while operating income came in at 51.03M.
| Revenue | 1.10B |
| Gross Profit | 489.37M |
| Operating Income | 51.03M |
| Pretax Income | -84.51M |
| Net Income | -90.50M |
| EBITDA | 76.23M |
| EBIT | 1.85M |
| Earnings Per Share (EPS) | -0.32 |
As of September 30, 2026, Well Health Technologies Corp. holds 152.27M in cash and equivalents against 640.42M in total debt, resulting in a net debt position of 422.02M. Total book value stands at 560.60M, with working capital of 146.57M providing operational flexibility.
| Cash & Cash Equivalents | 152.27M |
| Total Debt | 640.42M |
| Net Debt | 422.02M |
| Equity (Book Value) | 560.60M |
| Book Value Per Share | 2.19 |
| Working Capital | 146.57M |
Well Health Technologies Corp. produced 80.18M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -28.61M in capital expenditures, free cash flow totaled 51.57M - equivalent to 0.20 per share.
| Operating Cash Flow | 80.18M |
| Capital Expenditures | -28.61M |
| Free Cash Flow | 51.57M |
| FCF Per Share | 0.20 |
Over the twelve months ended September 30, 2026, Well Health Technologies Corp. posted a gross margin of 44.61, reflecting its pricing power and cost economics. The operating margin of 4.65 and net profit margin of -8.25 provide insight into operational efficiency.
| Gross Margin | 44.61 |
| Operating Margin | 4.65 |
| Pretax Margin | -7.70 |
| Profit Margin | -8.25 |
| EBITDA Margin | 6.95 |
Over the twelve months ended September 30, 2026, Well Health Technologies Corp. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.31, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -19.52, meaning Well Health Technologies Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -19.52 |
| FCF Yield | 6.31 |
As of September 30, 2026, Well Health Technologies Corp. has an Altman Z-Score of 3.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.25 |
Already premium?